🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate whether PF-02545920 reduces the effects of ketamine on brain ac...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2011-04
Trial ID
NCT01244880
Treatments Being Tested
To evaluate the safety and tolerability of multiple doses of PF 02545920 ad...
Status
Completed
Location
California Clinical Trials Medical Group
Start Date
2013-03-06
Trial ID
NCT01829048
Treatments Being Tested
This Phase 1 study will evaluate PDE10 enzyme occupancy using Positron Emis...
Status
Completed
Location
Karolinska Trial Alliance (KTA) M62
Start Date
2014-03
Trial ID
NCT01918202
Treatments Being Tested
To evaluate the safety and tolerability of multiple doses of PF-02545920 su...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-10
Trial ID
NCT00463372
Treatments Being Tested
To assess the efficacy and safety of an investigational compound PF-0254592...
Status
Terminated
Location
California Clinical Trials Medical Group, Inc.
Start Date
2007-11
Trial ID
NCT00570063
Treatments Being Tested
This study is a 12 month open label extension study of PF-02545920 20 mg do...
Status
Terminated
Location
The Kirkland Clinic of UAB Hospital
Start Date
2015-02-25
Trial ID
NCT02342548
Treatments Being Tested
This study is a 26 week, randomized, parallel group, double blind compariso...
Status
Completed
Location
The Kirklin Clinic of UAB Hospital
Start Date
2014-09
Trial ID
NCT02197130
Treatments Being Tested
This study aims to evaluate whether PF-02545920 is safe and effective in th...
Status
Completed
Location
K & S Professional Research Services, LLC
Start Date
2010-10
Trial ID
NCT01175135
Treatments Being Tested
This study aims to evaluate whether PF-02545920 is safe and effective in th...
Status
Terminated
Location
Birmingham Psychiatry Pharmaceutical Studies, Inc.
Start Date
2013-10
Trial ID
NCT01939548
Treatments Being Tested
We hypothesize that PF-02545920 will increase glucose metabolism in a part ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-05
Trial ID
NCT01103726
Treatments Being Tested